
Digital Pathology Solutions announces strategic partnership with leading European laboratory network
Expanding AI-powered diagnostics across 50+ clinical laboratories in Western and Central Europe, with rollout starting in Q3 2026.
Announcements, research write-ups, and engineering notes from the team building clinical-grade AI for pathology.

Expanding AI-powered diagnostics across 50+ clinical laboratories in Western and Central Europe, with rollout starting in Q3 2026.
NewsExpanding AI-powered diagnostics across 50+ clinical laboratories in Western and Central Europe, with rollout starting in Q3 2026.
Read article
NewsA significant step forward in regulatory-approved AI diagnostics, making the algorithm available to US laboratories later this year.
Read article
NewsOur quality management system is now certified to the international standard for medical devices, marking a foundational step on the path to full CE IVDR approval.
Read article
NewsOur latest research demonstrates unprecedented accuracy in PD-L1 scoring across multiple cancer types, with implications for companion diagnostics.
Read article
NewsThe round, led by a European health-tech fund with participation from existing investors, will accelerate CE IVDR submissions and expand our clinical deployment team.
Read article
NewsPathologyAI will coordinate the computational pathology workstream of a €9M multi-institutional research programme on clinically explainable AI for cancer diagnostics.
Read article
NewsExpanding AI-powered diagnostics across 50+ clinical laboratories in Western and Central Europe, with rollout starting in Q3 2026.
Read article
NewsA significant step forward in regulatory-approved AI diagnostics, making the algorithm available to US laboratories later this year.
Read article
NewsOur quality management system is now certified to the international standard for medical devices, marking a foundational step on the path to full CE IVDR approval.
Read article
NewsOur latest research demonstrates unprecedented accuracy in PD-L1 scoring across multiple cancer types, with implications for companion diagnostics.
Read article
NewsThe round, led by a European health-tech fund with participation from existing investors, will accelerate CE IVDR submissions and expand our clinical deployment team.
Read article
NewsPathologyAI will coordinate the computational pathology workstream of a €9M multi-institutional research programme on clinically explainable AI for cancer diagnostics.
Read article
NewsExpanding AI-powered diagnostics across 50+ clinical laboratories in Western and Central Europe, with rollout starting in Q3 2026.
Read article
NewsA significant step forward in regulatory-approved AI diagnostics, making the algorithm available to US laboratories later this year.
Read article
NewsOur quality management system is now certified to the international standard for medical devices, marking a foundational step on the path to full CE IVDR approval.
Read article
NewsOur latest research demonstrates unprecedented accuracy in PD-L1 scoring across multiple cancer types, with implications for companion diagnostics.
Read article
NewsThe round, led by a European health-tech fund with participation from existing investors, will accelerate CE IVDR submissions and expand our clinical deployment team.
Read article
NewsPathologyAI will coordinate the computational pathology workstream of a €9M multi-institutional research programme on clinically explainable AI for cancer diagnostics.
Read article
BlogA single accuracy number hides more than it reveals. Here is how we measure model fairness across sites, scanners, and patient subpopulations before we ship.
Read article
BlogHow we built a whole-slide image viewer that renders gigapixel pathology data at 60fps on commodity hardware.
Read article
BlogA practitioner-oriented look at what separates a research-grade AI model from something you can trust a patient's biopsy to.
Read article
BlogTwelve months after adopting a foundation-model backbone across our indication heads, here is an honest technical account of what we gained and what it cost us.
Read article
BlogEvery hospital LIS is different, and every pathologist's tolerance for new software is lower than you think. Notes from three years of field deployments.
Read article
BlogClinical-grade AI is not judged on paper benchmarks. It is judged on whether a senior pathologist trusts it at 4 PM on a Friday. Here is how we designed for that moment.
Read article
BlogA single accuracy number hides more than it reveals. Here is how we measure model fairness across sites, scanners, and patient subpopulations before we ship.
Read article
BlogHow we built a whole-slide image viewer that renders gigapixel pathology data at 60fps on commodity hardware.
Read article
BlogA practitioner-oriented look at what separates a research-grade AI model from something you can trust a patient's biopsy to.
Read article
BlogTwelve months after adopting a foundation-model backbone across our indication heads, here is an honest technical account of what we gained and what it cost us.
Read article
BlogEvery hospital LIS is different, and every pathologist's tolerance for new software is lower than you think. Notes from three years of field deployments.
Read article
BlogClinical-grade AI is not judged on paper benchmarks. It is judged on whether a senior pathologist trusts it at 4 PM on a Friday. Here is how we designed for that moment.
Read article
BlogA single accuracy number hides more than it reveals. Here is how we measure model fairness across sites, scanners, and patient subpopulations before we ship.
Read article
BlogHow we built a whole-slide image viewer that renders gigapixel pathology data at 60fps on commodity hardware.
Read article
BlogA practitioner-oriented look at what separates a research-grade AI model from something you can trust a patient's biopsy to.
Read article
BlogTwelve months after adopting a foundation-model backbone across our indication heads, here is an honest technical account of what we gained and what it cost us.
Read article
BlogEvery hospital LIS is different, and every pathologist's tolerance for new software is lower than you think. Notes from three years of field deployments.
Read article
BlogClinical-grade AI is not judged on paper benchmarks. It is judged on whether a senior pathologist trusts it at 4 PM on a Friday. Here is how we designed for that moment.
Read article
NewsA significant step forward in regulatory-approved AI diagnostics, making the algorithm available to US laboratories later this year.
Read article
NewsOur quality management system is now certified to the international standard for medical devices, marking a foundational step on the path to full CE IVDR approval.
Read article
NewsOur latest research demonstrates unprecedented accuracy in PD-L1 scoring across multiple cancer types, with implications for companion diagnostics.
Read articleSubscribe or reach out and we’ll get back to you within one business day.
